The David H. Koch Institute for Integrative Cancer Research At MIT

About

  • Director's Message
  • Future
  • Scientific Advisory Board
  • FAQs
  • Administration

Faculty

Research Areas

  • Nanotechnology Therapy
  • Detection and Monitoring
  • Metastasis
  • Pathways and Resistance
  • Immune System

facilities

  • The Koch Institute
  • Core Facilities

News and Events

  • Press Kit
  • Summer Symposium

Contact

Support

  • Make a Gift Now
  • Naming Opportunities
  • Bequests and Trusts
  • Corporate Giving
  • Gifts of Stock
  • Gifts of Other Assets

The next generation in cancer research... Because the next generation is waiting.

Skip to content

Biology + Engineering = Real Progress

A Nobel-worthy track record for biological discovery. World-class engineering expertise. That is the cocktail with which MIT is changing the course of cancer research. The David H. Koch Institute for Integrative Cancer Research at MIT is the epicenter of a highly collaborative effort to fight cancer in ways it has never been fought before. Science and engineering. The molecular and the technological. Working together to lengthen lives by controlling cancer.

News

Important advance in RNAi delivery
Team develops safe, effective RNA interference technique... more >>

MIT breaks ground for Koch institute
The institute, scheduled to open in December 2010, will house 25 laboratories occupied by MIT engineers, scientists and clinicians... more >>

Uncovering a protective role of microRNA
Genetic snippets linked to cancer also key to embryonic cell development... more >>

David H. Koch gives $100 million to MIT for cancer research
MIT has announced a $100 million gift from Koch Industries... more >>

Tyler Jacks on the new David H. Koch Institute
Tyler Jacks, director of the Koch Institute, discusses... more >>

Summer Symposium
"Nanotechnology and Cancer: The Power of Small Science"... more >>

Cancer Study shows power of interdisciplinary approach
A UCLA cancer study reported in this month's Nature... more >>

'Micro' livers could aid drug screening
MIT researchers have devised a novel way to create tiny... more >>

Remote-control nanoparticles deliver drugs directly into tumors
MIT scientists have devised remotely controlled nanoparticles that... more >>

The Cantoni Memorial Lecture Series: Biology & Biochemistry of Small RNA.
more >>

MIT works toward novel therapeutic device
MIT and University of Rochester researchers report important... more >>

Amon, Golub win cancer prize: Paul Marks Prize recognizes significant research contributions
MIT Professor Angelika Amon and Todd R. Golub will share... more >>

  • Press
  • Summer Symposium 2008
  • Oncology Boston